A case report of the effect of plasma exchange on reactive hemophagocytic syndrome associated with toxic shock syndrome

Therapeutic Apheresis and Dialysis

Volumn 8, Issue 6, 2004, Pages 503-506

  Sanada, Satoru ^a   Ookawara, Susumu ^a   Shindo, Tetsurou ^a   Morino, Kazuma ^a   Ishikawa, Hiroyasu ^a   Suzuki, Masayuki ^a  

^a Yamagata Prefectural Central Hospital   (Japan)

Author keywords

Hemophagocytic syndrome; Macrophage colony stimulating factor; Plasma exchange; Staphylococcus aureus; Toxic shock syndrome

Indexed keywords

ANTIBIOTIC AGENT; CATECHOLAMINE; CILASTATIN PLUS IMIPENEM; COLONY STIMULATING FACTOR 1; STAPHYLOCOCCUS ENTEROTOXIN A; TOXIN ANTIBODY; VANCOMYCIN;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CULTURE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; GENERAL CONDITION IMPROVEMENT; HEMOPHAGOCYTIC SYNDROME; HUMAN; LABORATORY DIAGNOSIS; MACROPHAGE; MALE; MORTALITY; PHYSICAL EXAMINATION; PLASMAPHERESIS; PRIORITY JOURNAL; RESUSCITATION; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; SYMPTOMATOLOGY; THROMBOCYTE COUNT; TOXIC SHOCK SYNDROME; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MIDDLE AGED; PLASMA EXCHANGE; SHOCK, SEPTIC;

EID: 11444265123     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1774-9987.2004.00188.x     Document Type: Article

References (30)

1. Risdall RJMR, Nesbit ME, Krivit W, Balfour HH Jr, Simmons RL, Brunning RD. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979;44:993-1002.
2. Imashuku S. Differential diagnosis of hemophagocytic syndrome: Underlying disorders and selection of the most effective treatment. Int J Hematol 1997;66:135-51.
3. Lee GR, Bithell TC, Fester J, Athens JW, Lukens JN. Clinical Hematology. Philadelphia, London: Lea & Febiger 1993;2189-91.
4. Risdall RJ, Brunning RD, Hernandez JI, Gordon DH. Bacteria-associated hemophagocytic syndrome. Cancer 1984;54:2968-72.
5. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis 2000;6:601-8.
6. Bouffandeau B, Mofredj A, Blanc S. Hemophagocytic syndrome in the critically ill. Intensive Care Med 2001;27:948-9.
7. Reiner A, Spivak J. Hemophagocytic histiocytosis a report of 23 new patients and a review of the literature. Medicine 1988;67:369-88.
8. Janka G, Imashuku S, Elinder G, Schneider M, Henter JI. Infection- and malignancy-associated hemophagocytic syndrome. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998;12:435-44.
9. Kaito K, Kobayashi M, Katayama T et al. Prognostic factors in hemophagocytic syndrome in adults: analysis of 34 cases. Eur J Haematol 1997;59:247-53.
10. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991;18:29-33.
11. Osugi Y, Hara J, Tagawa S et al. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood, 1997;89:4100-3.
12. Ishii E, Ohga S, Aoki T et al. Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: correlation with levels of serum interleukin-1 and tumor necrosis factor. Acta Haematol 1991;85:93-9.
13. Fujiwara F, Hibi S, Imashuku S. Hypercytokinemia in hemophagocytic syndrome. Am J Pediatr Hematol Oncol 1993;15:92-8.
14. Francois B, Trimoreau F, Vignon P, Fixe P, Praloran V, Gastinne H. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med 1997;103:114-20.
15. Wright SW, Trott AT. Toxic shock syndrome: a review. Ann Emerg Med 1988;17:268-73.
16. Uchiyama T, Yan X-J, Imanishi K, Yagi J. Bacterial superantigens: mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious disease. Microbiol Immunol 1994;38:245-56.
17. Jarraud S, Peyrat MA, Lim A et al. egc, a highly prevalent operon of enterotoxin gene, forms a putative nursery of superantigens in Staphylococcus aureus. J Immunol 2001;166:669-77.
18. Praloran V, Gascan H, Papin S, Chevalier S, Trossaert M, Boursier MC. Inducible production of macrophage colony stimulating factor (CSF1) by malignant and normal human T-cells. Leukemia 1990;4:411-4.
19. Oyama Y, Amano T, Hirakawa S, Hironaka K, Suzuki S, Ota Z. Haemophagocytic syndrome treated with cyclosporin A. a t-cell disorder. Br J Haematol 1989;73:276-8.
20. Rokyta R, Novak I, Matejovic M, Sramek V, Hora P, Jindra P. Hemophagocytic syndrome in the critically ill. Intensive Care Med 2000;26:1712.
21. Becton DL, Kurtzberg J, Kinney TR, Friedman HS, Chaffee S, Falletta JM. Treatment of lymphohistiocytic erythrophagocytosis with VP-16 and aziridinylbenzoquine. Med Pediatr Oncol 1987;15:58-61.
22. Freeman BRM, Salman E, Joyee MJ, Pitel P. Intravenously administered immune globulin for the treatment of infection-associated hemophagocytic syndrome. J Pediatr 1993;123:479-81.
23. Dwyer JM. Manipulating the immune system with immune globulin. N Engl J Med 1992;326:107-24.
24. Rosen FS. Putative mechanisms of the effect of intravenous γ-globulin. Clin Immunol Immunopathol 1993;67(Suppl):S41-3.
25. Dietrich G, Kaveri S-V, Kazatchkine MD. Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network. Clin Immunol Immunopathol 1992;62 (Suppl):S73-81.
26. Nagasawa M, Okawa H, Yata J. Deleterious effects of high dose γ-globulin therapy on patients with hemophagocytic syndrome. Int J Hematol 1994;60:91-3.
27. Aukrust P, Froland SS, Liabakk N-B et al. Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo. Blood 1994;84:2136-43.
28. Satomi A, Nagai S, Nagai T et al. Effect of plasma exchange on refractory hemophagocytic syndrome complicated with myelodysplastic syndrome. Ther Apher 1999;3:317-9.
29. Goto S, Aoike I, Shibasaki Y et al. A successfully treated case of disseminated tuberculosis-associated hemophagocytic syndrome and multiple organ dysfunction syndrome. Am J Kid Dis 2001;38:E19.
30. Imashuk S, Hibi S, Ohara T et al. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Blood 1999;93:1869-74.